Aripiprazole: An FDA Approved Bioactive Compound to treat schizophrenia-A Mini Review.

CONCLUSION: The present article embarks the available information on Aripiprazole with emphasis on its clinical pharmacology, mechanism of action, pharmacokinetics, pharmacodynamics, metabolism and clinical trials.
PMID: 30306873 [PubMed - as supplied by publisher]

Source: Current Drug Discovery Technologies - October 8, 2018 Category: Drugs & Pharmacology Authors: Kumar A, Singh H, Mishra A, Mishra AK Tags: Curr Drug Discov Technol Source Type: research